Headlines about Analogic (NASDAQ:ALOG) have trended somewhat positive recently, Accern Sentiment reports. Accern scores the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Analogic earned a daily sentiment score of 0.24 on Accern’s scale. Accern also assigned news coverage about the medical research company an impact score of 46.2604042082744 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

ALOG has been the topic of several recent analyst reports. Zacks Investment Research raised shares of Analogic from a “hold” rating to a “buy” rating and set a $97.00 price objective on the stock in a research report on Friday, December 8th. Jefferies Group reissued a “hold” rating and set a $80.00 price objective on shares of Analogic in a research report on Friday, December 8th. Finally, BidaskClub downgraded shares of Analogic from a “hold” rating to a “sell” rating in a research report on Thursday, December 7th.

Shares of Analogic (NASDAQ ALOG) opened at $84.40 on Tuesday. Analogic has a 1 year low of $66.00 and a 1 year high of $89.50. The company has a market cap of $1,053.71, a PE ratio of -14.76, a P/E/G ratio of 4.22 and a beta of 0.86.

Analogic (NASDAQ:ALOG) last announced its quarterly earnings data on Wednesday, December 6th. The medical research company reported $0.75 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.43 by $0.32. Analogic had a negative net margin of 15.06% and a positive return on equity of 5.09%. The company had revenue of $106.90 million for the quarter, compared to the consensus estimate of $100.55 million. During the same period in the prior year, the firm posted $0.43 EPS. Analogic’s revenue for the quarter was down 11.7% on a year-over-year basis. analysts anticipate that Analogic will post 2.86 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 29th. Investors of record on Friday, December 15th were given a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a yield of 0.47%. The ex-dividend date was Thursday, December 14th. Analogic’s dividend payout ratio (DPR) is -6.99%.

COPYRIGHT VIOLATION WARNING: “Analogic (ALOG) Earning Somewhat Favorable Media Coverage, Report Finds” was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The correct version of this report can be viewed at https://www.dailypolitical.com/2018/01/16/analogic-alog-earning-somewhat-favorable-media-coverage-report-finds.html.

About Analogic

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Insider Buying and Selling by Quarter for Analogic (NASDAQ:ALOG)

Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.